Catalyst Wire Dossier Catalyst Wire Dossier

Flixabi

infliximab · Samsung Bioepis NL B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flixabi, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: EMA Authorised: Flixabi (infliximab) — Samsung Bioepis NL B.V.

See pricing